Elizabeth D. Pratico, Ph.D. - Publications
Affiliations: | Duke University, Durham, NC |
Area:
DNA as a catalystYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Pratico ED, Feger BJ, Watson MJ, Sullenger BA, Bowles DE, Milano CA, Nair S. RNA-mediated reprogramming of primary adult human dermal fibroblasts into c-kit+ cardiac progenitor cells. Stem Cells and Development. PMID 26176491 DOI: 10.1089/scd.2015.0073 | 0.459 | |||
2015 | Pratico ED, Nair SK, Sullenger BA. 66. Identification and Characterization of a B Cell Aptamer That Targets Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Myelogenous Leukemia (CML) Molecular Therapy. 23: S29. DOI: 10.1016/S1525-0016(16)33671-1 | 0.604 | |||
2014 | Kotula JW, Sun J, Li M, Pratico ED, Fereshteh MP, Ahrens DP, Sullenger BA, Kovacs JJ. Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth. Plos One. 9: e93441. PMID 24736311 DOI: 10.1371/Journal.Pone.0093441 | 0.571 | |||
2013 | Pratico ED, Sullenger BA, Nair SK. Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40. Nucleic Acid Therapeutics. 23: 35-43. PMID 23113766 DOI: 10.1089/Nat.2012.0388 | 0.563 | |||
2012 | Kotula JW, Pratico ED, Ming X, Nakagawa O, Juliano RL, Sullenger BA. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Therapeutics. 22: 187-95. PMID 22703281 DOI: 10.1089/Nat.2012.0347 | 0.58 | |||
2007 | Pratico ED, Silverman SK. Ty1 reverse transcriptase does not read through the proposed 2',5'-branched retrotransposition intermediate in vitro. Rna (New York, N.Y.). 13: 1528-36. PMID 17652136 DOI: 10.1261/Rna.629607 | 0.612 | |||
2005 | Pratico ED, Wang Y, Silverman SK. A deoxyribozyme that synthesizes 2',5'-branched RNA with any branch-site nucleotide. Nucleic Acids Research. 33: 3503-12. PMID 15967808 DOI: 10.1093/Nar/Gki656 | 0.643 | |||
Show low-probability matches. |